Clinical evaluation of acupuncture effects based on the theory of Meridian-Viscera Association

Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Matching the diagnostic criteria of CSAP according to the Chinese Society of Cardiology;
•2. Meeting Class I or II of the Canadian Cardiovascular Society (CCS) angina pectoris severity grade;
•3. Aging from 45 to 70 years;
•4. Having experienced angina attack in at least the last three months, and the attack frequency >= twice a week in the most recent month;
•5. At least 2 months of standardized medication history before enrolment (sustaining the same medication, usage, and dose). Basic therapeutic drug is one or more of the following: ß-blockers, angiotensin converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers(ARB), antiplatelet medications and statins;
•6. Having signed informed consent.

•1. Being pregnant or during lactation or intending to be pregnant in the 6 months;
•2. Having severe cardiovascular, digestive, urinary, respiratory, hematological, nervous, or endocrine system diseases that cannot be controlled with clinical treat-ments;
•3. Converting to acute coronary syndrome (including acute myocardial infarction and unstable angina pectoris), serious arrhythmia (advanced atrioventricular block, ventricular tachycardia, supraventricular tachycardia, frequent premature beats);
•4. Being accompanied with serious psychiatric illness;
•5. Failing to control hypertension (systolic blood pressure >= 140 mm Hg and/or diastolic blood pressure >= 90 mm Hg) or diabetes mellitus (HbA1 above 7% in last three months);
•6. Having received acupuncture therapy due to cardiovascular illness in the last 1 month;
•7. Having bleeding tendency and dermatitis;
•8. Being in allergic constitution and be allergic to adhesive tape;
•9. Participating in any other clinical trials.

发起方

Chengdu University of Traditional Chinese Medicine